4.7 Article

Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

Luis Ibanez-Samaniego et al.

Summary: Hepatitis C virus (HCV) infection is associated with neuropsychiatric disturbances that impact functioning and health-related quality of life. This study found that eradication of HCV can decrease cognitive impairment prevalence and improve functioning and HRQoL, with older patients and those with baseline cognitive impairment benefitting the most. Persistent cognitive impairment may be associated with factors like higher cardiovascular risk, cirrhosis, lower education, and higher anxiety and depression scores.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Immunology

Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa

Elihu Aranday-Cortes et al.

Summary: The study found that despite the high diversity of HCV genotypes/subtypes in Africa, DAAs combinations still achieved high SVR rates, except for certain subtypes that responded poorly to the commonly used sofosbuvir/ledipasvir regimen.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Gastroenterology & Hepatology

Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study

Harmanpreet Kaur et al.

Summary: This study demonstrates that sustained virological response can improve neuropsychiatric manifestations and quality of life in patients with chronic hepatitis C. Factors associated with cure include adherence, high ALT levels, and scores on the depression inventory.

JOURNAL OF VIRAL HEPATITIS (2022)

Article Neurosciences

Effect of gender difference on psychiatric outcomes for hepatitis C virus patients receiving direct-acting antivirals in Egyptian population: a cohort study

Zainab Gaber Mahran et al.

Summary: This study evaluated the psychiatric manifestations, specifically depression and anxiety symptoms, in chronic hepatitis C patients receiving sofosbuvir-based direct-acting antiviral agents (DAAs). The results showed that DAA treatment significantly improved anxiety and depression symptoms in CHC patients, with no gender differences observed. High levels of extraversion were found to increase the risk of depression.

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2022)

Review Medicine, General & Internal

Extrahepatic Manifestations of Chronic HCV Infection

Patrice Cacoub et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Neurosciences

Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study

Gloria Vaghi et al.

JOURNAL OF NEUROVIROLOGY (2020)

Article Gastroenterology & Hepatology

Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents

Oguzhan Kesen et al.

TURKISH JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents

Silvia Goni-Esarte et al.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2019)

Article Virology

Flaviviruses and the Central Nervous System: Revisiting Neuropathological Concepts

Olga A. Maximova et al.

ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)

Article Clinical Neurology

Neurobiology and Neuroimaging of Chronic Hepatitis C Virus: Implications for Neuropsychiatry

Sarah L. Martindale et al.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)

Article Gastroenterology & Hepatology

Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin

Mary Ellen Dias Barbosa et al.

BMC GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Sarah Blach et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

Matthias Gotte et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Clinical Neurology

Hepatitis C viral infection and the risk of dementia

W-C Chiu et al.

EUROPEAN JOURNAL OF NEUROLOGY (2014)

Review Infectious Diseases

Flaviviruses are neurotropic, but how do they invade the CNS?

J. W. Neal

JOURNAL OF INFECTION (2014)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

JOURNAL OF HEPATOLOGY (2013)

Review Psychology, Clinical

Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis

Marc Udina et al.

JOURNAL OF CLINICAL PSYCHIATRY (2012)

Article Clinical Neurology

The size and burden of mental disorders and other disorders of the brain in Europe 2010

H. U. Wittchen et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)

Editorial Material Gastroenterology & Hepatology

Neuropsychological alterations in hepatitis C infection: The role of inflammation

Marco Senzolo et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Preventing relapse of major depression during interferon-α therapy for hepatitis C -: A pilot study

Ondria C. Gleason et al.

DIGESTIVE DISEASES AND SCIENCES (2007)

Article Medicine, General & Internal

Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants

Chien-Hung Chen et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2007)

Article Immunology

Emerging evidence of hepatitis C virus neuroinvasion

T Laskus et al.

Article Psychology, Clinical

Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy

MR Kraus et al.

JOURNAL OF CLINICAL PSYCHIATRY (2003)

Article Gastroenterology & Hepatology

Fatigue in patients with chronic hepatitis C

T Poynard et al.

JOURNAL OF VIRAL HEPATITIS (2002)

Review Gastroenterology & Hepatology

Hepatitis C, interferon alfa, and depression

D Zdilar et al.

HEPATOLOGY (2000)